Our findings revealed that the PR-enriched genes were associated with tumor specific T cells (Fig. 3a), and PR patients displayed higher abundance of tumor specific T cells, evidenced by elevated levels of CD8A, CXCL13, and IFNG genes (Fig. 3b). This evidence concerns the gene CD8A and neoplasm.